Related Experiment Video
Updated: Jun 28, 2026
08:19
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
Published on: November 17, 2015
17.8K
A Comprehensive Analysis of Liposomal-Based Nanocarriers for Treating Skin and Soft Tissue Infection
Dyala M Khasawneh1, Rami J Oweis1, Mo'tasem Alsmadi1,2
1Institute of Nanotechnology, Jordan University of Science and Technology, Irbid, Jordan.
Current Drug Delivery
|August 13, 2024
Summary
Nanoliposomes offer improved topical delivery for bacterial skin infections (SSTIs), overcoming limitations of traditional methods. This review guides liposome design for effective SSTI treatment by matching carriers to infection specifics.
Area of Science:
- Pharmacology
- Biotechnology
- Dermatology
Background:
- Bacterial skin and soft tissue infections (SSTIs) are common, with topical treatments preferred for safety and efficacy.
- Current topical delivery systems for SSTIs face challenges like poor drug release control, skin irritation, and limited permeability.
- Nanoliposomes have emerged as promising carriers for topical SSTI management, but specific design guidelines are lacking.
Purpose of the Study:
- To review bacterial SSTIs, including epidemiology, classification, microbiology, and management strategies.
- To highlight the role of liposome-based nanovesicles in enhancing topical antibiotic and natural compound delivery for SSTIs.
- To provide a framework for designing liposomal formulations tailored to specific SSTI characteristics.
Main Methods:
- Comprehensive literature review of bacterial SSTIs and nanoliposome applications.
- Analysis of liposomal formulation parameters and their impact on therapeutic outcomes.
- Development of a guide for matching liposome characteristics to infection types and causative agents.
Main Results:
- Nanoliposomes significantly enhance local antibiotic and natural antibacterial agent delivery for SSTIs.
- Liposomal formulation modifications directly influence therapeutic efficacy and treatment outcomes.
- A strategic approach to liposome design is crucial for optimizing topical SSTI management.
Conclusions:
- Nanoliposomes represent a significant advancement in topical drug delivery for bacterial SSTIs.
- Tailoring liposome properties to specific infections is key to maximizing therapeutic benefits.
- This review provides essential knowledge for developing next-generation liposomal treatments for SSTIs.
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...